NCT00076284View on ClinicalTrials.gov

GW873140 to Treat HIV-1 Infected Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

March 31, 2005

Conditions
HIV Infections
Interventions
DRUG

GW873140

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00076284 - GW873140 to Treat HIV-1 Infected Adults | Biotech Hunter | Biotech Hunter